ALMANAC
ALMANAC is the name of a major breast cancer trial. The acronym stands for Axillary Lymphatic Mapping Against Nodal Axillary Clearance. This major randomized trial performed in several centers in the UK produced clear evidence that sentinel node biopsy (SNB), used to stage axillary spread of disease, can be used with low failed localization and false negative rates, provided both radioisotope and blue dye are used to locate the sentinel nodes.[1]
References[edit | edit source]
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD, Spt
